Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Global Custom Recombinant Protein Production Services Market, by Expression System (Mammalian, Bacteria, Insect, Yeast, and Others), by End User (Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 2,600.21 million in 2017, and is projected to exhibit a CAGR of 11.2% during the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights.
Growth of the Global research and development of products and services.
Key players in the market focus on research and development for a wide range of applications such as medicine and biotechnology. For example, in 2015, Abgent was offering ELITE custom antibody services including custom antibody development, custom peptide synthesis, and custom protein expression services.
*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2737
Furthermore, growth of the global custom recombinant protein production services market is expected to be driven by by market players to increase their production capacity. For example, in February 2018, Lakepharma, Inc. established a new facility in Massachusetts to offer fully integrated Contract Development and Manufacturing Organization (CDMO) services to provide end-to-end services to clients and partners. Likewise, Lakepharma, Inc. launched LakePharma MicroBiomanufacturing Center in Hopkinton in February 2018 to enhance its product manufacturing and development capabilities.
Moreover, the Global Custom Recombinant Protein Production Services Market is expected to grow through the rising expenditure on research and development. For example, according to the National Bureau of Statistics, February 2018, China’s expenditure on research and development increased from 10.6% in 2016 to 11.6% in 2017 reaching US$ 280 billion in 2017.
Key market players are adopting strategies such as acquisitions and collaborations to improve their services and offerings. For example, in 2017, Eurofins acquired Villapharma Research SL based in Spain to expand its portfolio of services and strengthen its service proposition for the pharmaceutical and biotech industries.
Browse 37 Market Data Tables and 29 Figures spread through 190 Pages and in-depth TOC on ‘Custom Recombinant Protein Production Services Market’- Global Forecast to 2026, by Expression System (Mammalian, Bacteria, Insect, Yeast, and Others), by End User (Research Institutes, Biotechnology, and Pharmaceutical Companies, Contract Research Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the custom recombinant protein production services market Press Release, click the link below: https://www.coherentmarketinsights.com/press-release/custom-recombinant-protein-production-services-market-to-surpass-us-67-billion-by-2026-1438
Key Takeaways of the Custom Recombinant Protein Production Services Market:
- The global custom recombinant protein production services market is expected to witness a CAGR of 11.2% during the forecast period (2018 – 2026) due to advances in bioreactor systems that have reduced production time for recombinant proteins. In 2014, according to the National Center for Biotechnology Information (NCBI), around 65.6% of clinical scale manufacturers and around 42% of commercial manufacturers adopted single-use bioreactors to improve their bioprocessing capabilities.
- In 2018, the mammalian segment dominated the custom recombinant protein production services market. This is due to its ability to offer an optimized transient system for the rapid production of mammalian expression protein.
- In 2018, the biotechnology and pharmaceutical companies segment dominated the custom recombinant protein production services market among end-users due to the rising number of research and development activities. According to Pharmaceutical Research and Manufacturers of America (PhRMA), 2016, member companies invested an estimated US$ 58.8 billion in research and development in 2015, which was the majority of all biopharmaceutical research and development spending in the U.S.
- Key players operating in the global custom recombinant protein production services market include GenScript Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma Discovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, Sino Biological Inc., and SignalChem Lifesciences Corporation.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2737
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027